Analysis of symptoms and management modalities of endometriosis in a tertiary care hospital
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20240469Keywords:
Endometriosis, Infertility, Ovarian endometrioma, Pelvic pain, Retrograde menstruationAbstract
Background: Endometriosis is a progressive disease characterized by the growth and placement of endometrial tissue outside the uterine cavity. Endometriosis affects 10-15% of all women of reproductive age and 70% of women with chronic pelvic pain. We have aimed to study the demographic factors, symptoms and management of endometriosis. Certain risk factors are discussed which may be helpful in early diagnosis of the same.
Methods: A one year hospital based retrospective study involving detailed medical records of patients presenting with endometriosis between 1st November 2022 and 31st October 2023.
Results: Majority of cases of endometriosis were found in the reproductive age group. Several patients presented with multiple symptoms, of which common ones were pelvic pain, dysmenorrhea, dyspareunia and infertility. Management modalities include medical management using GnRH agonist like injection leuprolide and surgical management techniques involving laparoscopy and laparotomy depending upon the extent of involvement. The most common site of endometriosis was found to be the ovary, while other peroperative findings included distorted anatomy and a concomitant infective focus owing to pelvic inflammatory diseases.
Conclusions: Endometriosis can decrease quality of life due to severe pain, fatigue, infertility. No preventative measures have yet been found. But early diagnosis and management may be extremely helpful in improving the quality of life.
References
Parasar P, Ozcan P, Terry KL. Endometriosis: epidemiology, diagnosis and clinical management. Curr Obstet Gynecol Rep. 2017;6:34-41.
Chauhan S, More A, Chauhan V, Kathane A, Chauhan Sr VV. Endometriosis: a review of clinical diagnosis, treatment, and pathogenesis. Cureus. 2022;14(9).
Taylor HS, Pal L, Sell E. Endometriosis. Section V. In: Speroff’s clinical Gyneocologic endocrinology and infertility. First South Asian edition. India: Wolters Kluwer; 2023:1223-1258.
Indian centre for endometriosis. American society for reproductive medicine classification of endometriosis. Available from: https://www.endometriosis-india.com/classification-of-endometriosis/. Accessed on 12 November 2023.
Barrier BF, Malinowski MJ, Dick EJ Jr, Hubbard GB, Bates GW. Adenomyosis in the baboon is associated with primary infertility. Fertil Steril. 2004;82(Suppl. S3):1091-4.
Schenken RS, Asch RH, Williams RF, Hodgen GD. Etiology of infertility in monkeys with endometriosis: luteinized unruptured follicles, luteal phase defects, pelvic adhesions, and spontaneous abortions. Fertil Steril. 1984;41:122.
Elizur SE, Lebovitz O, Weintraub AY, Eisenberg VH, Seidman DS, Goldenberg M, et al. Pelvic inflammatory disease in women with endometriosis is more severe than in those without. Aust N Z J Obstet Gynecol. 2014;54:162-5.
Kobayashi H. Similarities in pathogenetic mechanisms underlying the bidirectional relationship between endometriosis and pelvic inflammatory disease. Diagnostics. 2023;13(5):868.
Barbieri RL, Niloff JM, Bast RC Jr, Schaetzl E, Kistner RW, Knapp RC. Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril. 1986;45:630.
Pittaway DE, Fayez JA. The use of CA-125 in the diagnosis and management of endometriosis. Fertil Steril. 1986;46:790.
Vercellini P, Buggio L, Somigliana E. Role of medical therapy in the management of deep rectovaginal endometriosis. Fertil Steril. 2017;108:913-30.
Chen LH, Lo WC, Huang HY, Wu HM. A lifelong impact on endometriosis: pathophysiology and pharmacological treatment. Int J Mol Sci. 2023;24(8):7503.
